You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
Registering provides access to this and other free content.
Already have an account?Login Now.
This on-demand webinar from Invivoscribe describes the advantages of using a highly validated and precise companion diagnostic in the assessment of FLT3 mutations in AML patients.
The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.